These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 21654832)

  • 1. Polo-like kinase 1 is a potential therapeutic target in human melanoma.
    Jalili A; Moser A; Pashenkov M; Wagner C; Pathria G; Borgdorff V; Gschaider M; Stingl G; Ramaswamy S; Wagner SN
    J Invest Dermatol; 2011 Sep; 131(9):1886-95. PubMed ID: 21654832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted depletion of Polo-like kinase (Plk) 1 through lentiviral shRNA or a small-molecule inhibitor causes mitotic catastrophe and induction of apoptosis in human melanoma cells.
    Schmit TL; Zhong W; Setaluri V; Spiegelman VS; Ahmad N
    J Invest Dermatol; 2009 Dec; 129(12):2843-53. PubMed ID: 19554017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of CRM1-mediated nucleocytoplasmic transport: triggering human melanoma cell apoptosis by perturbing multiple cellular pathways.
    Pathria G; Wagner C; Wagner SN
    J Invest Dermatol; 2012 Dec; 132(12):2780-90. PubMed ID: 22832492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RNA interference-mediated silencing of the polo-like kinase 1 gene enhances chemosensitivity to gemcitabine in pancreatic adenocarcinoma cells.
    Yu C; Zhang X; Sun G; Guo X; Li H; You Y; Jacobs JL; Gardner K; Yuan D; Xu Z; Du Q; Dai C; Qian Z; Jiang K; Zhu Y; Li QQ; Miao Y
    J Cell Mol Med; 2008 Dec; 12(6A):2334-49. PubMed ID: 18266952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Up-regulation of pro-apoptotic protein Bim and down-regulation of anti-apoptotic protein Mcl-1 cooperatively mediate enhanced tumor cell death induced by the combination of ERK kinase (MEK) inhibitor and microtubule inhibitor.
    Kawabata T; Tanimura S; Asai K; Kawasaki R; Matsumaru Y; Kohno M
    J Biol Chem; 2012 Mar; 287(13):10289-10300. PubMed ID: 22270368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Small molecule inhibition of polo-like kinase 1 by volasertib (BI 6727) causes significant melanoma growth delay and regression in vivo.
    Cholewa BD; Ndiaye MA; Huang W; Liu X; Ahmad N
    Cancer Lett; 2017 Jan; 385():179-187. PubMed ID: 27793694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted knockdown of polo-like kinase 1 alters metabolic regulation in melanoma.
    Gutteridge RE; Singh CK; Ndiaye MA; Ahmad N
    Cancer Lett; 2017 May; 394():13-21. PubMed ID: 28235541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Up-regulation of Mcl-1 is critical for survival of human melanoma cells upon endoplasmic reticulum stress.
    Jiang CC; Lucas K; Avery-Kiejda KA; Wade M; deBock CE; Thorne RF; Allen J; Hersey P; Zhang XD
    Cancer Res; 2008 Aug; 68(16):6708-17. PubMed ID: 18701495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of PLK-1 silencing on endothelial cells and cancer cells of diverse histological origin.
    Gomes CP; Gomes-da-Silva LC; Ramalho JS; de Lima MC; Simões S; Moreira JN
    Curr Gene Ther; 2013 Jun; 13(3):189-201. PubMed ID: 23531193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polo-like kinase-1 immunoreactivity is associated with metastases in cutaneous melanoma.
    Kaczorowski M; Borowiec T; Donizy P; Pagacz K; Fendler W; Lipinski A; Halon A; Matkowski R
    J Cutan Pathol; 2017 Oct; 44(10):819-826. PubMed ID: 28626898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bcl-2 degradation is an additional pro-apoptotic effect of polo-like kinase inhibition in cholangiocarcinoma cells.
    Sydor S; Jafoui S; Wingerter L; Swoboda S; Mertens JC; Gerken G; Canbay A; Paul A; Fingas CD
    World J Gastroenterol; 2017 Jun; 23(22):4007-4015. PubMed ID: 28652654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polo-like kinase 1 (Plk1) is expressed by cutaneous T-cell lymphomas (CTCLs), and its downregulation promotes cell cycle arrest and apoptosis.
    Nihal M; Stutz N; Schmit T; Ahmad N; Wood GS
    Cell Cycle; 2011 Apr; 10(8):1303-11. PubMed ID: 21436619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apoptotic effects of genistein, biochanin-A and apigenin on LNCaP and PC-3 cells by p21 through transcriptional inhibition of polo-like kinase-1.
    Seo YJ; Kim BS; Chun SY; Park YK; Kang KS; Kwon TG
    J Korean Med Sci; 2011 Nov; 26(11):1489-94. PubMed ID: 22065906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The fatty acid binding protein 7 (FABP7) is involved in proliferation and invasion of melanoma cells.
    Slipicevic A; Jørgensen K; Skrede M; Rosnes AK; Trøen G; Davidson B; Flørenes VA
    BMC Cancer; 2008 Sep; 8():276. PubMed ID: 18826602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmaceutically inhibiting polo-like kinase 1 exerts a broad anti-tumour activity in retinoblastoma cell lines.
    Schwermer M; Dreesmann S; Eggert A; Althoff K; Steenpass L; Schramm A; Schulte JH; Temming P
    Clin Exp Ophthalmol; 2017 Apr; 45(3):288-296. PubMed ID: 27647547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined Inhibition of MEK and Plk1 Has Synergistic Antitumor Activity in NRAS Mutant Melanoma.
    Posch C; Cholewa BD; Vujic I; Sanlorenzo M; Ma J; Kim ST; Kleffel S; Schatton T; Rappersberger K; Gutteridge R; Ahmad N; Ortiz/Urda S
    J Invest Dermatol; 2015 Oct; 135(10):2475-2483. PubMed ID: 26016894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aurora B is regulated by the mitogen-activated protein kinase/extracellular signal-regulated kinase (MAPK/ERK) signaling pathway and is a valuable potential target in melanoma cells.
    Bonet C; Giuliano S; Ohanna M; Bille K; Allegra M; Lacour JP; Bahadoran P; Rocchi S; Ballotti R; Bertolotto C
    J Biol Chem; 2012 Aug; 287(35):29887-98. PubMed ID: 22767597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Downregulation of Polo-like kinase-1 (PLK-1) expression is associated with poor clinical outcome in uveal melanoma patients.
    Berus T; Markiewicz A; Kobylinska K; Biecek P; Orlowska-Heitzman J; Romanowska-Dixon B; Donizy P
    Folia Histochem Cytobiol; 2020; 58(2):108-116. PubMed ID: 32602935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. siRNA targeting PLK-1 induces apoptosis of synoviocytes in rheumatoid arthritis.
    Wada M; Kawahito Y; Kimura S; Kohno M; Ishino H; Kimura M; Omoto A; Yamamoto A; Hamaguchi M; Tsubouchi Y; Tokunaga D; Hojo T; Ashihara E; Maekawa T; Yoshikawa T
    Biochem Biophys Res Commun; 2007 Jun; 357(2):353-9. PubMed ID: 17434144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravenous liposomal delivery of the short hairpin RNAs against Plk1 controls the growth of established human hepatocellular carcinoma.
    Deng H; Jiang Q; Yang Y; Zhang S; Ma Y; Xie G; Chen X; Qian Z; Wen Y; Li J; Yang J; Chen L; Zhao X; Wei Y
    Cancer Biol Ther; 2011 Feb; 11(4):401-9. PubMed ID: 21150280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.